Light-based cancer treatment before surgery for bile duct cancer
Part of Cancer clinical trials.
This trial tests a treatment called PDT (photodynamic therapy) given before surgery to help control locally advanced bile duct cancer (cholangiocarcinoma). It may help shrink or better treat the cancer prior to an operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old.
- You have locally advanced bile duct cancer that can be removed by surgery (or possibly removed).
- You have not had chemotherapy or radiotherapy before joining the study.
- You can sign consent and attend follow-up visits.
- You are not pregnant or breastfeeding, and you don’t have a mental health condition that would prevent study participation.
- You are not allergic to porphyrin medicines, and you don’t have porphyria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs (gemcitabine, cisplatin, nab-paclitaxel) with an immunotherapy (rilvegostomig) before and after surgery for intrahepatic cholangiocarcinoma that can be completely removed. It aims to see if this approach improves outcomes.
This trial tests whether treating hilar bile duct cancer with either radiofrequency ablation (heat) or photodynamic therapy (light-activated medicine) can help patients when surgery isn’t an option. It aims to treat the tumor directly without planned surgery soon.
This trial tests a combination of an immunotherapy (adebrelimab), a targeted therapy (apatinib), and two chemotherapy drugs (gemcitabine and cisplatin) given before surgery for biliary tract cancers that are removable but at high risk of coming back. The goal is to see if this approach helps shrink the tumor and improve outcomes after surgery.
This trial tests a combination of chemotherapy, an immunotherapy drug (adebrelimab), and a drug to boost white blood cells (mecapegfilgrastim) before surgery for people with biliary tract cancer. The goal is to see if this approach can shrink the tumor enough to make surgery possible.
This trial tests whether receiving chemotherapy (cisplatin, gemcitabine, and nab-paclitaxel) before surgery can improve outcomes for people with high-risk bile duct or gallbladder cancer. It compares this approach to going straight to surgery.
This trial tests a combination of chemotherapy and immunotherapy before surgery for locally advanced bile duct cancer. The goal is to see if this approach can shrink the tumor enough to improve surgical outcomes.
Hear when a new Cholangiocarcinoma Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.